Koninklijke DSM N.V.

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 20 feb 2013 - 06:43
  • Statutory name Koninklijke DSM N.V.
  • Title DSM is positioned for strong EBITDA growth and increases dividend
  • Comments • DSM reports a solid Q4 with EBITDA of €243 million • EBITDA full year 2012 of €1,109 million with growth in all clusters, except for caprolactam • Robust performance of Life Sciences driven by Nutrition • Materials Sciences performed well, except for caprolactam • Strong cash generation from operating activities of €730 million in 2012 • Dividend increase proposed to €1.50 per ordinary share • Outlook 2013: moving towards EBITDA of €1.4 billion

Related downloads

201302200000000011_Presentation to investors full year results 2012.pdf
201302200000000011_Press release and Financial summary-pdf.pdf

Date last update: 17 January 2021

Share information

Share on: Share this